Duchenne Muscular Dystrophy Clinical Trial
— DMDOfficial title:
Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | May 8, 2025 |
Est. primary completion date | March 21, 2025 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 13 Years to 18 Years |
Eligibility | Inclusion Criteria: - Being diagnosed with Duchenne muscular dystrophy - To be literate in Turkish - To have scored 27 points or more on the Modified Mini Mental Test - Having a computer, tablet and internet connection - Volunteering to participate in the study by their parents and reading and signing the informed consent form Exclusion Criteria: - Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy - Having a cooperation problem that prevents completing the assessments for any reason - Difficulty understanding and speaking the Turkish language |
Country | Name | City | State |
---|---|---|---|
Turkey | Lokman Hekim University | Ankara |
Lead Sponsor | Collaborator |
---|---|
Basak Çagla Arslan | Hacettepe University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Demographic information form | At the start of the evaluations | ||
Primary | Modified Mini Mental State Test | before and after the eight-week intervention programs | ||
Primary | Vignos lower extremity functional scale | This scale was developed to assess the level of ambulation in neuromuscular diseases and consists of 10 stages. In this scale, the ambulation level of the person decreases from the first stage to the tenth stage. | before and after the eight-week intervention programs | |
Primary | Brooke upper extremity functional classification scale | This scale was developed to assess the functional levels of the upper extremity in neuromuscular diseases and consists of 6 stages. In this scale, progression from the first stage to the sixth stage indicates a decrease in the functionality of the upper extremity. | before and after the eight-week intervention programs | |
Primary | The Pediatric Quality of Life Inventory 3.0 Neuromuscular Module | before and after the eight-week intervention programs | ||
Primary | Canadian Occupational Performance Measure | before and after the eight-week intervention programs | ||
Primary | The Hospital Anxiety and Depression Scale (HADS) | Of the total 14 items in the scale, odd-numbered items measure anxiety and even-numbered items measure depression. The scores to be obtained from the sub-dimensions of the scale are between 0-21. The measurement results of the sub-dimensions indicate clinical distress with a total score of 7.5 for anxiety and a total score of 5.5 for depression. For each subscale, there are recommended cut-off scores of 8-10 points for mild severity, 11-15 points for moderate severity and 16 points and above for severe severity. | before and after the eight-week intervention programs | |
Primary | The Pediatric Quality of Life Inventory Multidimensional Fatigue Scale | This scale consists of 18 items and 3 subsections: general fatigue (6 items), fatigue during sleep/rest (6 items) and cognitive fatigue (6 items). Separate scores can be calculated for each subsection and the total score is obtained by summing the scores obtained from these sections. High scores indicate low fatigue. | before and after the eight-week intervention programs | |
Primary | The Numeric Rating Scale - Pain | This scale uses a 10-centimeter line. The left beginning of the line represents "no pain" (0 points) and the end of the line represents "excruciating pain" (10 points). | before and after the eight-week intervention programs |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05575648 -
Dual Task in Duchenne Muscular Dystrophy
|
N/A | |
Terminated |
NCT03907072 -
Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06450639 -
An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT04335942 -
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
|
N/A | |
Active, not recruiting |
NCT04906460 -
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02500381 -
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
|
Phase 3 | |
Enrolling by invitation |
NCT05967351 -
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
|
Phase 3 | |
Recruiting |
NCT03067831 -
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Recruiting |
NCT01834040 -
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Completed |
NCT02246478 -
A Study of TAS-205 for Duchenne Muscular Dystrophy
|
Phase 1 | |
Active, not recruiting |
NCT01772043 -
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
|
N/A | |
Terminated |
NCT01168908 -
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT00758225 -
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
|
Phase 2 | |
Completed |
NCT03680365 -
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
|
||
Recruiting |
NCT03513367 -
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.
|
||
Recruiting |
NCT05712447 -
Duchenne Muscular Dystrophy Video Assessment Registry
|
||
Recruiting |
NCT01484678 -
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
|
||
Completed |
NCT03319030 -
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
|
||
Terminated |
NCT01753804 -
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
|
N/A | |
Completed |
NCT02530905 -
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
|
Phase 1 |